GENVOYA®▼

(elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide)

GENVOYA® is a once-daily single-tablet regimen1 containing:

  • emtricitabine (FTC) and tenofovir alafenamide fumarate (TAF); two nucleoside reverse transcriptase inhibitors (NRTIs), and
  • elvitegravir (EVG), an integrase strand transfer inhibitor (INSTI), boosted with cobicistat (c).